Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease Article (Faculty180)

cited authors

  • Meighani, Alireza; Hart, Benjamin R; Bourgi, Kassem; Miller, Nichole; John, Ajin; Ramesh, Mayur


  • Fecal microbiota transplantation (FMT) has recently been shown to be a promising therapy for recurrent and refractory Clostridium difficile infections (CDI) despite lack of protocol standardization. Patients with inflammatory bowel disease (IBD) present a particular challenge to CDI therapy as they are reported to have worse clinical outcomes, including higher colectomy rates and increased mortality. We aimed to assess the outcomes of FMT for recurrent CDI in patients with IBD at our healthcare system.


publication date

  • 2017

published in

start page

  • 2870

end page

  • 2875


  • 62